Posts by Sandra Ansanay-Alex
Molesense Raised CHF 150,000 from VentureKick
The Swiss medtech startup’s sweat-based molecular tracking aims to prevent preterm births and empower doctors with continuous, personalised data.
Read MoreTubulis Raises €308 Million Series C
The German company, that recently set foot at Biopôle Lausanne, generates antibody-drug conjugates to fight ovarian cancer and lung adenocarcinomas.
Read MoreONWARD Medical Raised €50 Million in Capital Increase
ONWARD Medical, a leading neurotechnology company headquartered in the Netherlands, with R&D operations in Lausanne Switzerland and a US office in Boston, is developing therapies to restore movement and independence in people with spinal cord injuries, and has successfully raised over €50 million through a private placement of new shares. The capital increase, backed by…
Read MoreRed Drop Receives a FIT Impact Grant
Red Drop offers home self-sampling kits that use menstrual blood to obtain health information and receive healthcare support.
Read MoreSihuan Pharmaceutical Invests in Suisselle SA
Sihuan Pharmaceutical Holdings Group (HKG:0460) announced that it has made a capital investment in Swiss medical aesthetics company Suisselle, according to a statement released on Monday to the Hong Kong Stock Exchange. The pharmaceutical group did not disclose the financial terms of the transaction. Sihuan Pharmaceutical previously obtained the exclusive distribution rights for Suisselle’s CELLBOOSTER®…
Read MorePartial heart transplant performed at HUG, a European first
This highly technical procedure was carried out on a 12-year-old patient with complex congenital heart disease.
Read MoreSOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
SOPHiA GENETICS is a leader in AI-driven precision medicine based in Lausanne (Switzerland). The company announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions. SOPHiA DDM™ Digital Twins uses each patient’s unique…
Read More19th Innovation Day at HUG: Meet the Winners!
At their 19th Innovation Day, the Geneva University Hospitals (HUG) highlighted 16 innovative projects from the hospital and academic sectors, grouped into three categories: Proof of Concept, Prototype, and Launch-Ready Product. Top 3 Awarded Projects: 🥇 Flow Twin: A 3D modeling platform of brain vessels for training, planning personalized endovascular procedures, and testing new…
Read MoreADC Therapeutics Announces $60 Million Private Placement
ADC Therapeutics SA, a Vaud-based commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), announced that it has entered into securities purchase agreements for the sale of its equity securities to certain institutional investors in a $60.0 million private investment in public equity (“PIPE”) financing. In the PIPE, ADC Therapeutics…
Read MoreHealth.Tech Global Summit
The Health.Tech Global Summit is taking place from 2 to 4 March 2027 in Basel The health.tech Glocal Summit brings together global leaders, innovators, and visionaries at the forefront of healthcare transformation. Through expert guidance and collaboration, the event delivers groundbreaking insights, meaningful connections, and a future-focused vision for the industry. More than 5,000…
Read More